[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"chalazion\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:chalazion":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,42,66],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":24,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100627581","effect-of-different-concentrations-of-sevoflurane-for-anesthesia-induction-in-pediatric-ophthalmic-surgery-100627581",false,"NCT07450495","Effect of Different Concentrations of Sevoflurane for Anesthesia Induction in Pediatric Ophthalmic Surgery","Effectiveness and Safety of 6% Versus 8% Sevoflurane for Anesthesia Induction in Pediatric Ophthalmic Minor Surgery: A Randomized Controlled Trial","SEVO-PED","Inclusion Criteria:\n\n* Children aged 1 to 6 years (12-72 months)\n* Scheduled to undergo minor ophthalmic surgery (e.g., chalazion excision) under general anesthesia\n* American Society of Anesthesiologists (ASA) physical status I\n* Assessed as suitable for inhalation anesthesia by anesthesiologists\n* Written informed consent obtained from parents or legal guardians\n\nExclusion Criteria:\n\n* ASA physical status II or higher\n* Known hepatic or renal dysfunction\n* Congenital heart disease\n* History of malignant hyperthermia\n* Known allergy to sevoflurane\n* History of asthma or severe respiratory disease\n* Upper respiratory tract infection within the past 4 weeks\n* Anticipated difficult airway\n* Refusal of participation by parents or legal guardians","ALL","1 Year","6 Years",{"count":21,"type":22},80,"ESTIMATED","INTERVENTIONAL",[25],"NA","This randomized controlled trial aims to compare the effectiveness and safety of 6% versus 8% sevoflurane inhalation induction in pediatric patients undergoing minor ophthalmic surgery. The primary outcome is emergence agitation assessed using the Pediatric Anesthesia Emergence Delirium (PAED) scale. Secondary outcomes include hemodynamic parameters, induction time, recovery time, and adverse events.",[28],"Chalazion","RECRUITING","2026-02-27",{"date":32,"type":33},"2026-03-04","ACTUAL",{"date":35,"type":33},"2025-02-25",{"date":37,"type":22},"2026-04-01",{"name":39,"class":40},"Joint Shantou International Eye Center of Shantou University and the Chinese University of Hong Kong","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":17,"minAge":48,"maxAge":4,"enrollmentInfo":49,"targetDuration":4,"studyType":23,"phases":51,"briefSummary":52,"conditions":53,"keywords":4,"overallStatus":54,"whyStopped":4,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":65},"100624092","evaluation-of-effectiveness-and-safety-of-intense-pulsed-light-treatment-for-chalazion-100624092","NCT07405138","Evaluation of Effectiveness and Safety of Intense Pulsed Light Treatment for Chalazion","Inclusion Criteria:\n\n* Subject is able to read, understand, and sign an Informed Consent Form (ICF)\n* 18 years of age or older\n* Clinical diagnosis of chalazion in the inflammatory stage\n* Subject is willing to comply with all study procedures-\n\nExclusion Criteria:\n\n* Concurrent eyelid infection\n* Chalazion with atypical features, which to the opinion of the study investigator is inadequate for a study\n* Recurring Chalazion\n* Floppy eyelid syndrome\n* Demodex blepharitis patients taking Lotilaner ophthalmic solution within 30 days prior to screening\n* Ocular surgery within 3 months prior to screening\n* Current diagnosis of malignant tumors in the affected eyelid, including:\n\nsebaceous carcinoma and basal cell carcinoma\n\n* Laser Assisted In Situ Keratomileusis (LASIK)\u002FSmall Incision Lenticule Extraction (SMILE) surgery, within 1 year prior to screening\n* Radial Keratotomy (RK) surgery\n* Recent ocular trauma, within 3 months prior to screening\n* Pre-cancerous lesions or skin cancer in the planned treatment area\n* Severe active allergies, or other severe uncontrolled eye disorders affecting the ocular surface\n* Uncontrolled infections or uncontrolled immunosuppressive diseases\n* Best corrected visual acuity worse than 20\u002F200 in either eye\n* Ocular surface abnormality that may compromise corneal integrity in either eye (e.g., prior chemical burn, Epithelial Basement Membrane Dystrophy - EBMD)\n* Within 1 week prior to screening, use of photosensitive medication and\u002For herbs that may cause sensitivity to 560-1200 nm light exposure, including: Isotretinoin, Tetracycline, Doxycycline, and St. John's Wort\n* Active sun burn in the treatment area\n* Anterior chamber inflammation\n* Corneal edema\n* Any condition revealed w","18 Years",{"count":50,"type":22},40,[25],"To study the effectiveness and safety of IPL treatment for Chalazion",[28],"NOT_YET_RECRUITING","2026-02-17",{"date":57,"type":33},"2026-02-19",{"date":59,"type":22},"2026-02-04",{"date":61,"type":22},"2026-12",{"name":63,"class":64},"Lumenis Be Ltd.","INDUSTRY",2,{"id":67,"slug":68,"hasResults":11,"nctId":69,"briefTitle":70,"officialTitle":70,"acronym":71,"eligibilityCriteria":72,"healthyVolunteers":11,"sex":17,"minAge":48,"maxAge":4,"enrollmentInfo":73,"targetDuration":4,"studyType":23,"phases":75,"briefSummary":77,"conditions":78,"keywords":79,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":85,"lastUpdatePostDateStruct":86,"startDateStruct":88,"completionDateStruct":90,"leadSponsor":92,"locationsCount":41},"100211102","phase-3-local-5-fluorouracil-injection-for-the-treatment-of-chalazia-a-prospective-comparative-study-100211102","NCT02025023","Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study","CTS","Inclusion Criteria:\n\n* Single or multiple chalazia in a single eyelid\n\nExclusion Criteria:\n\n* Chalazia present for less than one month and no previous injection or incision and curettage",{"count":74,"type":22},120,[76],"PHASE3","Local injection of 5-fluorouracil into a chalazion (stye) is as effective as local injection of triamcinolone (steroid) and incision and curettage for treatment of chalazia.",[28],[80,81,82,83,84],"Size","Pain","Resolution","Complications","Swelling","2020-02-04",{"date":87,"type":33},"2020-02-06",{"date":89,"type":4},"2013-12",{"date":91,"type":22},"2026-07",{"name":93,"class":40},"University of Washington"]